Control Study of Pharmacoeconomics about Elderly Diabetes Patients Drug Treatment Programmes

CHEN Li-fen

Abstract：Objective:To investigate the pharmacoeconomics of drug economics drug treatment of senile diabetes patients.Method:150 cases of elderly diabetes patients,admitted from January 2012 to December 2013 ,by using the method of random number table were divided into observation group and control group ,75 cases in each group.Control group patients accepted treatment of Glimepiride combined with Metformin,observation group of patients accepted Gliclazide combined with Metformin,then to compare and statistic the curative effect of two groups of patients,low blood sugar occurrence ,treatment cost and the effect of pharmacoeconomics.Result:Two groups of patients in treatment effect,the incidence of hypoglycemia and cost comparison differences had no statistical significance(P>0.05).Observation group of patients with drug economics effect was significantly lower than the control group,the difference was statistically significant(P<0.05).Conclusion:Gliclazide in combination with Metformin and Glimepiride combined with Metformin are very significant on the clinical effect of elderly diabetes,from the perspective of pharmacoeconomics,Gliclazide combined with Metformin more superiority and worthy for promoting from the perspective of pharmacoeconomics.